Pathos AI has secured $237 million in Series E funding to expand its agentic AI platform for drug development. The financing will support scaling of the company’s technology and advancement of its oncology pipeline.
Pathos AI Secures $237M in Series E Financing to Scale Agentic AI Drug Development Platform and Advance Oncology Pipeline – AI Insider
Leave a Comment
Leave a Comment